Log in to save to my catalogue

Identification of anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) oxystero...

Identification of anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) oxystero...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2506858764

Identification of anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) oxysterol derivatives in vitro

About this item

Full title

Identification of anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) oxysterol derivatives in vitro

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2021-02

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Abstract Development of effective antiviral drugs targeting the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) are urgently needed to combat the coronavirus disease 2019 (COVID-19). Oxysterols, defined as oxidized derivatives of cholesterol, include endogenous (naturally occurring) cholesterol metabolites as well as semi-synth...

Alternative Titles

Full title

Identification of anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) oxysterol derivatives in vitro

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2506858764

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2506858764

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2021.01.31.429001